The precise mechanism(s) by which NK activity is suppressed in patients with SLE is generally unknown. The present study was designed to focus on cellular defects per se in NK cells from patients with SLE. It was observed that the usual enhancing effect of interferon (IF) and IF inducers was markedly impaired in SLE patients. Of 24 SLE patients studied, 17 had significantly decreased NK activity relative to controls. NK activity had a significant negative correlation with clinical activity score (r = -0.56, P < 0.005) but was not correlated with corticosteroid dose, antinuclear antibody titers, total hemolytic complement (CH50), or sedimentation rate. Furthermore, significant depressions in NK activity correlated with variations in disease activity in six patients followed serially. De-pressed NK function could not be reversed by prolonged in vitro incubation at 370C or with protease treatment. Furthermore, depressed NK activity was not altered by removal of glass adherent cells nor was a suppression of NK activity in normal controls seen by the addition of SLE peripheral mononuclear cells. No reversal of depressed activity to normal levels was seen by the addition of indomethacin nor did the supernatants from SLE cell cultures cause a suppression of normal NK function. NK activity in SLE patients did not respond normally to IF inducers (poly-I:C and concanavalin A) even if the SLE patients had normal NK function. The response of SLE cells to exogenous IF was also impaired. The number of effector-target conjugates was quantitated with several target cells (K562, Yac-1, Fravel) in SLE patients and controls. A
A B S T R A C T Spontaneous cytotoxicity mediated by natural killer (NK) cells is impaired in several human diseases including systemic lupus erythematosus (SLE).
The precise mechanism(s) by which NK activity is suppressed in patients with SLE is generally unknown. The present study was designed to focus on cellular defects per se in NK cells from patients with SLE. It was observed that the usual enhancing effect of interferon (IF) and IF inducers was markedly impaired in SLE patients. Of 24 SLE patients studied, 17 had significantly decreased NK activity relative to controls. NK activity had a significant negative correlation with clinical activity score (r = -0.56, P < 0.005) but was not correlated with corticosteroid dose, antinuclear antibody titers, total hemolytic complement (CH50), or sedimentation rate. Furthermore, significant depressions in NK activity correlated with variations in disease activity in six patients followed serially. De- pressed NK function could not be reversed by prolonged in vitro incubation at 370C or with protease treatment. Furthermore, depressed NK activity was not altered by removal of glass adherent cells nor was a suppression of NK activity in normal controls seen by the addition of SLE peripheral mononuclear cells. No reversal of depressed activity to normal levels was seen by the addition of indomethacin nor did the supernatants from SLE cell cultures cause a suppression of normal NK function. NK activity in SLE patients did not respond normally to IF inducers (poly-I:C and concanavalin A) even if the SLE patients had normal NK function. The response of SLE cells to exogenous IF was also impaired. The number of effector-target conjugates was quantitated with several target cells (K562, Yac-1, Fravel) in SLE patients and controls. A Received for publication 3 June 1982 and in revised form 19 January 1983. significant correlation between the proportion of glass nonadherent mononuclear cells that formed effectortarget conjugates with these various targets and the magnitude of NK lysis was observed. However, SLE and normal subjects had equal numbers of effectortarget conjugates independent of NK function. Release of a soluble cytotoxic factor was induced with concanavalin A, and was markedly impaired in SLE patients relative to normal controls. Thus, impaired NK cell function in SLE does not appear to be related to cell-mediated suppressive mechanisms or to the deletion of effector cells; rather, the decreased NK activity may be related to an impaired release of a soluble cytotoxic factor.
INTRODUCTION
Natural cytotoxicity is thought to be a distinct arm of the host immune surveillance system (1) and may be important in the elimination of tumors (2) and virusinfected cells (3) . The natural killer (NK)l cell is morphologically a large granular lymphocyte (4) and can be partially purified with a number of techniques (5) . It spontaneously binds to susceptible targets and effects rapid lysis (6) . This progression of binding and subsequent lysis can be directly visualized and followed sequentially (7) . NK cell-mediated cytotoxicity is abnormal in a number of human disease states including systemic lupus erythematosus (SLE) (8), Sj6-gren's syndrome (9), Chediak-Higashi syndrome (10), malignant melanoma (11) , and advanced epitheliod carcinomas (12) . In SLE the abnormalities in NK func-tion can be profound (13, 14) , and in that respect present an ideal system for the study of derangements in this host defense mechanism.
Various studies have implicated antilymphocyte antibodies (ALA) (14) and immune complexes (13) in the pathogenesis of the defect in NK activity found in SLE. Primary abnormalities in lymphocyte function have been described in SLE (15, 16) , but cellular defects per se in NK effector cells have not been thoroughly evaluated. In spite of the presence of ALA reactive with NK effector cells (14) , an actual in vivo deletion of the mononuclear cell subpopulation responsible for NK activity has not been demonstrated. In addition, many SLE patients with decreased NK activity do not have detectable serum ALA (13) .
This study was designed to investigate NK activity in SLE and to focus on specific defects in the mononuclear cells that mediate NK activity. It was observed that the usual enhancing effect of interferon (IF) and IF inducers was markedly impaired in SLE patients. In addition, the release of natural killer cell cytotoxic factor (NKCF) that mediates NK cell lytic activity (17) , was also abnormal.
METHODS
Subjects. All patients included in this study were followed in the University of New Mexico Rheumatology Clinics and fulfilled the strict criteria for SLE as defined by the American Rheumatologic Association (18) . The patients were followed serially through exacerbations and remissions over the course of 2 yr. Clinical data are included in Table  I (20) . Cells from the interface were washed three times with phosphate-buffered saline, and resuspended in medium RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) with penicillin (100 IU/ml), streptomycin (100 jig/ml), and 10% heat-inactivated human AB serum. Cell viability was >99% as determined by trypan blue exclusion and contained from 2 to 20% monocytes by benzidine peroxidase staining (21) . PBMC at 5 X 106 cells/ml were resuspended in RPMI 1640 medium containing 10% human AB serum, placed in glass wool columns (0.5 g glass wool in a 10-ml plastic syringe barrel), and incubated for 30 Sequential addition of SLE cells to normal control cells. SLE cells were added to normal control PBMC (2.5 X 105 cells/well) in microtiter plates at the following SLE control ratios: 0:1, 0.2:1, 0.4:1, 0.6:1, and 1:1. These preparations were then cultured for 16 h before placement in the NK assay.
NKCF release assay. NKCF was induced in a manner similar to that described by Wright and Bonavida (17, 23) . Briefly, PBMC at 20 X 106 cells/ml in medium were incubated with Con A at 5 mg/ml at 370C for 36 h, subsequently the supernatant was harvested after centrifugation at 400 g for 5 min. Supernatants were stored at -70°C until use, at which time they were passed through a 0.45-,um filter. The NKCF activity of each supernatant was determined by pipetting 1 ml of K562 targets suspended in fresh medium at a concentration of 2 X 105 cells/ml and 0.1 ml of the NKCF supernatant into each of three wells of a sterile flat bottom microtiter plate. Control wells received, instead of supernatant, 0.1 ml of either medium or medium with Con A. For both controls, K562 viability at the end of the assay was >95%. Plates were incubated at 37°C in 5% CO2 for 48 h at which time K562 viability was determined by trypan blue exclusion. A minimum of 200 cells were counted per well, and the percentage of killed cells was determined. This percentage reflected the relative cytotoxic activity of each supernatant. Specificity of NKCF induced in this manner was essentially identical to that described previously (23) .
NK assay. K562 is a standard target for the human NK assay (24) and was used extensively in this study. YAC Effector-target conjugates. Effector-target conjugates were quantitated in a manner similar to that described by Roder et al. (6) . Briefly, 5 X 106 targets were suspended in RPMI 1640 without serum and 1 mg of fluorescein isothiocyanate (BDH, Chemicals Ltd., Poole, England) dissolved in 1 ml of normal saline was added. The cells were incubated on ice for 15 min, and then washed three times with cold RPMI 1640. 2.5 X 105 fluoresceinated targets were added to 2.5 X 105 glass wool nonadherent PBMC and the mixture was centrifuged at 400 g for 3 min and then incubated on ice for 2 h. Effector-target conjugates were identified on a fluorescent microscope. Adventitious associations between cells were eliminated by gently tapping the slide or coverslip. 400 cells were counted in each sample. At a 1:1 E/T ratio, the percentage of effectors that bound to target cells was counted. At a 50:1 E/T ratio the proportion of targets with adherent effector cells was measured.
Statistical methods. The two-tailed Student's t test was used to determine the significance of differences between the means of two groups. Linear regression analysis was used to compute linear correlation coefficients (r values) and P values between two variables.
RESULTS
NK function in SLE. NK activity in SLE patients as a group was significantly decreased relative to normal controls (Fig. 1) (Table II) . Importantly, patients with decreased NK tended to continue to show decreased NK when studied later, even during remissions. In addition, severely depressed NK activity was associated with clinical exacerbations in SLE disease activity in all six patients. These differences were highly significant (P < 0.05). Thus, it appears that SLE disease activity is closely related to deranged NK function. Effect of 24-h incubation. In an effort to see if soluble factors adherent to the cell membrane might. be responsible for decreased NK activity, SLE and normal control PBMC were incubated at 37°C for 24 h, washed, and then placed into the NK assay. There was no significant change in NK activity at 0 vs. 24 h for either SLE or normal controls (Table III) . Similarly, the differences between patients and controls persisted after 24-h incubation.
Depletion of glass adherent cells. SLE patients showed a slightly increased percentage of monocytes in the mononuclear cell suspensions as determined by peroxidase staining, but this difference was not significant (SLE = 16.8±6.0%, normals = 11.8+5.0%, P > 0.10). There was no clear correlation between NK activity and percentage of monocytes in either patients or controls. Removal of glass wool adherent cells in- . The response to indomethacin in both groups was not significantly different (P < 0.10). Addition of poly-I:C and Con A. Poly-I:C and Con A are known inducers of IF production (25, 26) . These inducers were incubated with PBMC suspensions and cultured for 16 h before determination of NK activity. As can be seen from Fig. 3 normal controls responded to poly-I:C far better than SLE patients. At a 50:1 ratio the percent increase in lysis was as follows: normal = 20.00±16%, SLE patients = 4.0±15.7% (P < 0.01). This effect was similar at different ratios. The effect of Con A on NK was essentially identical to that of poly-I:C. In addition, the difference between the normal and SLE groups became even more significant after addition of IF Table IV , only K562, the line susceptible to NK lysis, was readily bound by the mononuclear cells. Thus, binding as has been shown previously (6) , is a necessary step in NK lysis, and this particular visual assay was sensitive enough to detect such differences in target-effector binding. Next, the same assay was repeated in six normal controls and six SLE patients (Table V) . Although significant differences in NK activity were again evident, there are no significant differences in the number of effector-target conjugates. Thus, the population of glass wool non- adherent cells capable of binding the K562 target and hence possessing the potential of lysing this target were not significantly decreased in SLE.
NKCF release. NKCF release as measured by the percent lysis of K562 cells by Con A supernatants was 19.1±4.1% in SLE patients (n = 8) and 36.3±6.5% in normal controls (n = 6). This difference is significant (P < 0.05). Interestingly, three SLE patients with nor- In certain disease states monocytes can be selectively enriched by Ficoll-Hypaque separation and can interfere with in vitro assays of lymphocyte function (27) . Indeed, the percentage of monocytes in SLE was greater than normal controls. However, removal of monocytes by glass-wool adherence did not result in an increase in NK activity for either SLE patients or controls. Monocytes can also secrete prostaglandins (28) , and certain prostaglandins are highly suppressive of NK activity (29, 30) . Indomethacin caused a significant increase in NK activity in both patients and controls, presumably from inhibition of base-line production of prostaglandins. This increase did not correct the SLE NK abnormality relative to normals, implying that the basic defect is not due to increased prostaglandin synthesis in SLE with subsequent NK suppression.
In this study, effector-target conjugates were quantitated and there was no statistical difference between SLE patients and normal controls, despite concomitant differences in NK activity. Thus, SLE (36) . IF is thought to enhance NK activity by increasing recycling and also by recruitment of pre-NK cells (37, 38 (37) . In our study after 24-h 
